E. M. Proctor

922 total citations
39 papers, 721 citations indexed

About

E. M. Proctor is a scholar working on Infectious Diseases, Parasitology and Surgery. According to data from OpenAlex, E. M. Proctor has authored 39 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 14 papers in Parasitology and 8 papers in Surgery. Recurrent topics in E. M. Proctor's work include Amoebic Infections and Treatments (15 papers), Parasitic Infections and Diagnostics (12 papers) and Parasitic infections in humans and animals (7 papers). E. M. Proctor is often cited by papers focused on Amoebic Infections and Treatments (15 papers), Parasitic Infections and Diagnostics (12 papers) and Parasitic infections in humans and animals (7 papers). E. M. Proctor collaborates with scholars based in South Africa, Canada and United Kingdom. E. M. Proctor's co-authors include Jay S. Keystone, Richard Mathias, Patrick Doyle, William Bowie, S. J. Powell, J. N. Scragg, R. Elsdon‐Dew, Michael A. Gregory, Gary Garber and A. J. Wilmot and has published in prestigious journals such as Journal of Clinical Microbiology, Ophthalmology and Infection and Immunity.

In The Last Decade

E. M. Proctor

38 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. M. Proctor South Africa 15 382 365 131 110 91 39 721
Robyn Y. Shimizu United States 14 717 1.9× 942 2.6× 99 0.8× 48 0.4× 20 0.2× 20 1.1k
William B. Lushbaugh United States 18 428 1.1× 357 1.0× 206 1.6× 12 0.1× 183 2.0× 44 834
Ronald Silberman United States 9 208 0.5× 138 0.4× 103 0.8× 43 0.4× 61 0.7× 13 592
Norbert Ryan Australia 13 210 0.5× 318 0.9× 42 0.3× 27 0.2× 38 0.4× 19 667
Sema Ertuğ Türkiye 15 289 0.8× 715 2.0× 72 0.5× 150 1.4× 44 0.5× 79 1.0k
Semra Özçelik Türkiye 13 154 0.4× 154 0.4× 71 0.5× 56 0.5× 27 0.3× 63 508
B. Jaulhac France 14 524 1.4× 316 0.9× 41 0.3× 27 0.2× 63 0.7× 29 951
J P Ackers United Kingdom 19 577 1.5× 506 1.4× 374 2.9× 14 0.1× 221 2.4× 57 944
G M Faubert Canada 20 703 1.8× 1.1k 2.9× 49 0.4× 120 1.1× 9 0.1× 43 1.2k
William E. Aldeen United States 11 189 0.5× 153 0.4× 53 0.4× 28 0.3× 84 0.9× 12 428

Countries citing papers authored by E. M. Proctor

Since Specialization
Citations

This map shows the geographic impact of E. M. Proctor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. M. Proctor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. M. Proctor more than expected).

Fields of papers citing papers by E. M. Proctor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. M. Proctor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. M. Proctor. The network helps show where E. M. Proctor may publish in the future.

Co-authorship network of co-authors of E. M. Proctor

This figure shows the co-authorship network connecting the top 25 collaborators of E. M. Proctor. A scholar is included among the top collaborators of E. M. Proctor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. M. Proctor. E. M. Proctor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Young, Ian, DP Nicholls, Christopher M. Loughrey, et al.. (2016). The Northern Ireland Familial Hypercholesterolaemia cascade screening service. Atherosclerosis. 245. e248–e248. 1 indexed citations
2.
Proctor, E. M., et al.. (1994). The Seroepidemiology of Toxoplasmosis in the Lower Fraser Valley of British Columbia. Canadian Journal of Infectious Diseases and Medical Microbiology. 5(5). 218–223. 7 indexed citations
3.
Proctor, E. M.. (1993). Tunga penetrans Acquired while Traveling in Africa. Canadian Journal of Infectious Diseases and Medical Microbiology. 5(2). 82–83. 1 indexed citations
4.
Proctor, E. M., et al.. (1992). Enhanced Killing of Acanthamoeba Cysts in vitro Using Dimethylsulfoxide. Ophthalmology. 99(8). 1197–1200. 9 indexed citations
5.
Proctor, E. M.. (1991). Laboratory Diagnosis of Amebiasis. Clinics in Laboratory Medicine. 11(4). 829–859. 24 indexed citations
6.
Doyle, Patrick, et al.. (1990). Epidemiology and pathogenicity of Blastocystis hominis. Journal of Clinical Microbiology. 28(1). 116–121. 116 indexed citations
7.
Proctor, E. M., et al.. (1989). Isoenzyme Analysis of Human and Animal Isolates of Giardia Duodenalis from British Columbia, Canada. American Journal of Tropical Medicine and Hygiene. 41(4). 411–415. 27 indexed citations
8.
Proctor, E. M., et al.. (1988). Isoenzyme Patterns of Isolates of Trichomonas vaginalis from Vancouver. Sexually Transmitted Diseases. 15(4). 181–185. 11 indexed citations
9.
Proctor, E. M., et al.. (1987). Enzyme-linked Immunosorbent Assay for the Diagnosis of Trichomoniasis in Women. Sexually Transmitted Diseases. 14(4). 216–220. 8 indexed citations
10.
Garber, Gary, et al.. (1987). Cell culture compared with broth for detection of Trichomonas vaginalis. Journal of Clinical Microbiology. 25(7). 1275–1279. 38 indexed citations
11.
Proctor, E. M., et al.. (1987). Endemic institutional strongyloidiasis in British Columbia.. PubMed. 136(11). 1173–6. 12 indexed citations
12.
Proctor, E. M., et al.. (1987). The Electrophoretic Isoenzyme Patterns of Strains of Entamoeba Histolytica Isolated in Two Major Cities in Canada. American Journal of Tropical Medicine and Hygiene. 37(2). 296–301. 14 indexed citations
13.
Garber, Gary, E. M. Proctor, & William Bowie. (1986). Immunogenic proteins of Trichomonas vaginalis as demonstrated by the immunoblot technique. Infection and Immunity. 51(1). 250–253. 28 indexed citations
14.
Keystone, Jay S., et al.. (1983). Safety and efficacy of diphetarsone in the treatment of amoebiasis, non-pathogenic amoebiasis and trichuriasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 77(1). 84–86. 10 indexed citations
15.
Scragg, J. N. & E. M. Proctor. (1978). Further Experience with Mebendazole in the Treatment of Symptomatic Trichuriasis in Children. American Journal of Tropical Medicine and Hygiene. 27(2). 255–257. 14 indexed citations
16.
Proctor, E. M., et al.. (1973). Ultrastructure of cysts of E. histolytica. International Journal for Parasitology. 3(4). 455–456. 5 indexed citations
17.
Proctor, E. M., et al.. (1973). Ultrastructure of E. histolytica—Strain NIH 200. International Journal for Parasitology. 3(4). 457–460. 10 indexed citations
18.
Morris, Noah, E. M. Proctor, & R. Elsdon‐Dew. (1968). A physico-chemical approach to the serological diagnosis of cysticercosis.. 39(4). 41–4344. 7 indexed citations
19.
Proctor, E. M. & R. Elsdon‐Dew. (1966). Serological tests in porcine cysticercosis.. South African Journal of Science. 62(8). 264–266. 5 indexed citations
20.
Proctor, E. M., S. J. Powell, & R. Elsdon‐Dew. (1966). The serological diagnosis of cysticercosis. Annals of Tropical Medicine and Parasitology. 60(2). 146–151. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026